TPA-mediated regulation of osteopontin in human malignant glioma cells

Anticancer Research

Volumn 18, Issue 2 A, 1998, Pages 807-812

  Tucker, Mary A ^a   Chang, Pi Ling ^a   Prince, Charles W ^a   Gillespie, G Yancey ^b   Mapstone, Timothy B ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Kentucky   (United States)

Author keywords

Malignant glioma; Osteopontin; Protein kinase C; TPA

Indexed keywords

3,4,5 TRIMETHOXYBENZOIC ACID 8 (DIETHYLAMINO)OCTYL ESTER; CALCIMYCIN; MESSENGER RNA; OSTEOPONTIN; PHORBOL ESTER;

ARTICLE; GLIOMA CELL; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

CALCIUM; GLIOMA; HUMANS; OSTEOPONTIN; PROTEIN KINASE C; RNA, MESSENGER; SIALOGLYCOPROTEINS; TETRADECANOYLPHORBOL ACETATE; TUMOR CELLS, CULTURED;

EID: 0031811828     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Rubinstein LJ: Tumors of the central nervous system, Fascicle 6, Atlas of Tumor Pathology, second series, AFIP, Washington, DC., 1970.
2. Burger PC, Vogel FS: The brain tumors, In: Surgical pathology of the nervous system and its coverings, John Wiley and Sons, New York, pp. 223-458, 1982.
3. Morris JH, Schoene WC: The Nervous System. In: Pathologic Basis of Disease, Robbins SL, Cotran RS, and Kumar V, eds., W.B. Saunders Co., Philadelphia, pp. 1399-1410, 1984.
4. Walker AE, Robins M, Weinfield FD: Epidemiology of brain tumors: The National Survey of Intracranial Neoplasms. Neurology 35: 219-220, 1985.
5. Gillespie GY, Mahaley MS: Biological response modifier therapies for patients with malignant gliomas. In: Neuro-oncology. Primary malignant brain tumors. D.G.T. Thomas, ed., Hodder and Stroughton Limited, London, England, pp. 242-282, 1990.
6. Denhardt DT, Guo X: Osteopontin: a protein with diverse functions. FASEB J 7(15): 1475-1482, 1993.
7. Craig AM, Smith JH, Denhardt DT: Osteopontin, a transformation-associated cell adhesion phosphoprotein, is induced by 12-O-tetradecanoylphorbol 13-acetate in mouse epidermis. J Biol Chem 264(16): 9682-9689, 1989.
8. Senger DR, Asch BB, Smith BD, Perruzi CA, Dvorak HF: A secreted phosphoprotein marker of neoplastic transformation of both epithelial and fibroblastic cells. Nature 302: 714-715, 1983.
9. Craig AM, Nemir M, Mukherjee BB, Chambers AF, Denhardt DT: Identification of the major phosphoprotein secreted by many rodent cell lines as 2ar/osteopontin: enhanced expression in H-ras-transformed 3T3 cells. Biochem Biophys Res Commun 157: 166-173, 1988.
10. Bellahcene A, Castronovo V: Increased expression qf osteonectin and osteopontin, two bone matrix proteins, in human breast cancer. Amer J Path 146(1): 95-100, 1995.
11. Chambers AF, Wilson SM, Kerkvliet N, O'Malley FP, Harris JF, Casson AG: Osteopontin expression in lung cancer. Lung Cancer 15(3): 311-23, 1996.
12. Brown LF, Papadopoulos-Sergiou A, Berse, B, Manseau EJ, Tognazzi K, Perruzzi CA, Dvorak HF, Senger DR: Osteopontin expression and distribution in human carcinomas. Amer J Path 145(3): 610-23, 1994.
13. Tuck AB, O'Malley FP, Singhal H, Tonkin KS, Harris JF, Bautista D, Chambers AF: Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas. Arch of Path and Lab Med 121(6): 578-84, 1997.
14. Nishizuka Y: The family of protein kinase C for signal transduction. JAMA 262: 1826-33, 1989.
15. Nishizuka Y: Studies and perspectives of the protein kinase C family for cellular regulation. Cancer 63: 1892-1903, 1989.
16. Mastro AM: Phorbol Esters: Tumor promotion, cell regulation, and the immune response. In: Lymphokines. S.B., Mizel, ed., Academic Press, New York, Vol. 6, pp. 263-313, 1982.
17. Smith HH, Denhardt DT: Evidence for two pathways of protein kinase C induction of 2AR expression: correlation with mitogenesis. J Cell Physiol 139: 189-195, 1989.
18. Nishizuka Y: Protein kinases 5: protein kinase C and lipid signaling for sustained cellular responses. FASEB J 9: 484-496, 1995.
19. Tsai J-C, Goldman CK, Bharara S, Teng L-J, Mapstone TB, Gillespie GY: Protein kinase C mediates induced secretion of vascular endothelial growth factor by human glioma cell lines. Manuscript submitted, Neurosurgery, 1997.
20. Bigner DD, Bigner SH, Ponten J, Wertermark B, Mahaley Jr. MS, Ruoslahti E, Herschman H, Eng, LF, Wikstrand CJ: Heterogeneity of genotypic and phenotypic characteristics of fifteen permanent cells derived from human gliomas. J Neuropath Exp Neurol 40: 201-229, 1981.
21. Wikstrand CJ, Bigner DD: Surface antigens of human glioma cells shared with normal adult and fetal brain. Cancer Res 39: 3235-3243, 1979.
22. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
23. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, 2nd ed. (Cold Spring Harbor, New York: Cold Spring Harbor Laboratory), 1989.
24. Saitoh Y, Kuratsu J, Takeshima H, Yamamoto S, Ushio Y: Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab Invest 72(1): 55-63, 1995.
25. Oldberg A, Franzen A, Heinegard D: Cloning and sequence analysis of rat bone sialoprotein (osteopontin) DNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci USA 83: 8819-8823, 1986.
26. Bautista DS, Xuan J-W, Hota C, Chambers AF, Harris JF: A Monoclonal antibody against osteopontin inhibits RGD-mediated cell adhesion to osteopontin. Osteopontin: Role in Cell Signalling and Adhesion. Ann NY Acad Sci 760: 309-311, 1995.
27. Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM: The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J of Clin Invest 95(2): 713-724, 1995.
28. Senger DR, Perruzzi CA: Cell migration promoted by a potent GRGDS-containing thrombin-cleavage fragment of osteopontin. Biochim Biophys Acta 1314(1 -2): 13-24, 1996.
29. Hu DD, Hoyer JR, Smith JW: Characterization of the interaction between integrins and recombinant human osteopontin. Ann New York Acad Sciences 760: 312-314, 1995.
30. Gladson CL, Cheresh DA: Glioblastoma expression of vitronectin and the alpha v beta 3 integrin. Adhesion mechanism for transformed glial cells. J Clin Invest 88(6): 1924-1932, 1991.
31. Gladson CL: Expression of integrin alpha v beta 3 in small blood vessels of glioblastoma tumors. J Neuropath Exper Neurol 55(11): 1143-1149, 1996.
32. Craig AM, Denhardt DT: The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene 100: 163-171, 1991.
33. Baxter G, Oto E, Daniel-Issakani S, Strulovici B: Constitutive presence of a catalytic fragment of protein kinase C epsilon in a small cell lung carcinoma cell line. J Biol Chem 267(3): 1910-1917, 1992.
34. Kim CY, Giaccia AJ, Strulovici B, Brown JM: Differential expression of protein kinase C epsilon protein in lung cancer cell lines by ionising radiation. Brit J Cancer 66(5): 844-849, 1992.
35. Perletti G, Tessitore L, Sesca E, Pani P, Dianzani MU, Piccinini F: Epsilon PKC acts like a marker of progressive alignancy in rat liver, but fails to enhance tumorigenesis in rat hepatoma cells in culture. Biochem Biophysic Res Comm 221(3): 688-691, 1996.
36. Xiao H, Goldthwait DA, Mapstone T: The identification of four protein kinase C isoforms in human glioblastoma cell lines: PKC alpha, gamma, epsilon, and zeta. J Neurosurg 81(5): 734-740, 1994.
37. Cacace AM, Guadagno SN, Krauss RS, Fabbro D, Weinstein IB: The epsilon isoform of protein kinase C is an oncogene when overexpressed in rat fibroblasts. Oncogene 8: 2095-2104, 1993.
38. Cacace AM, Ueffing M, Philipp A, Han EK, Kolch W, Weinstein IB: PKC epsilon functions as an oncogene by enhancing activation of the Raf kinase. Oncogene 13(12): 2517-2526, 1996.
39. Ruoslahti E: Integrins. J Clin Invest 87: 1-5, 1981.
40. Freed E, Gailit J, van der Geer P, Ruoslahti E, Hunter TA: A novel integrin ß subunit is associated with the vitronectin receptor a subunit (ar) in a human osteosarcoma cell line and is a substrate for protein kinase C. Embo J 8: 2955-2965 1989.
41. Dedhar S: Integrins and tumor invasion. Bioessays 12: 583-590, 1990.